READ THE FULL ETST RESEARCH REPORT
Earth Science Tech, Inc. (OTCQB: ETST) continues to demonstrate the benefits of its transformation into a diversified healthcare company, reporting another quarter of profitable growth while expanding the breadth of its vertically integrated healthcare platform. Rather than relying on a single product or service, ETST has assembled a portfolio of complementary businesses that span patient care, pharmacy services, telemedicine, healthcare management and consumer health products, positioning the company to participate in several of the fastest-growing segments of the healthcare industry.
The company’s operating model is built around multiple synergistic businesses that work together to improve patient access while capturing value throughout the healthcare delivery process. ETST owns and operates specialty compounding pharmacy businesses that provide customized medications, telemedicine platforms that connect patients with licensed healthcare professionals, prescription fulfillment operations, healthcare clinics, and consumer health brands. This integrated approach allows the company to provide patients with a streamlined experience while generating recurring revenue from several points within the same healthcare ecosystem. As demand continues to grow for personalized medicine, virtual healthcare, and specialty pharmacy services, ETST believes its diversified platform provides an attractive foundation for long-term expansion.
That strategy continued to produce positive financial results during the fiscal first quarter ended June 30, 2026. Revenue increased to $9.0 million, compared with $8.8 million during the prior-year period, while gross profit improved to $6.3 million from $6.1 million a year earlier. More importantly, profitability accelerated at a much faster pace than revenue, with net income climbing 57% year over year to $715,697 from $456,714. Diluted earnings per share increased to $0.003, approximately three times the prior year’s level, reflecting both higher earnings and the benefits of a reduced share count following the company’s ongoing repurchase program.
Cash generation also showed meaningful improvement. Net cash provided by operating activities increased 108% year over year to $707,131, demonstrating that the company’s earnings growth is translating into stronger operating cash flow. Management attributed the improvement largely to enhanced working capital management, providing additional financial flexibility to support future growth initiatives.
The balance sheet also continued to strengthen during the quarter. Total assets increased to approximately $10.4 million, while shareholders’ equity rose to more than $7.3 million despite the company using cash to repurchase and retire over 3.7 million common shares. ETST remained free of long-term debt, a notable characteristic for a growing healthcare company, and management continues to deploy capital toward both expansion opportunities and shareholder-friendly initiatives such as share repurchases.
In conjunction with today’s earnings release, Chief Executive Officer Giorgio R. Saumat stated that the first-quarter results demonstrate the continued success of the company’s strategy of building a diversified, vertically integrated healthcare platform. He noted that management remains focused on disciplined execution, profitable growth, operational efficiency and expanding the company’s healthcare ecosystem while continuing to create long-term value for shareholders. The CEO also emphasized that ETST’s integrated business model enables the company to capitalize on multiple growth opportunities across pharmacy services, telemedicine and patient care rather than depending on a single revenue source.
Looking ahead, ETST appears well positioned to build upon this momentum. The combination of consistent profitability, improving cash flow, a debt-free balance sheet, expanding shareholder equity and an increasingly diversified healthcare platform provides a solid foundation for future growth. As telemedicine, specialty pharmacy and personalized healthcare continue to gain acceptance throughout the healthcare industry, Earth Science Tech has established a business model capable of participating in each of these expanding markets. With management continuing to execute its integrated growth strategy while producing improving financial results, ETST appears to be steadily strengthening its position as a profitable and diversified healthcare company with multiple avenues for long-term value creation.
SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you. Please visit our website for additional information on Zacks SCR.
DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks SCR provides and Zacks SCR receives payments totaling a maximum fee of up to $50,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE.
